Viewing Study NCT03740334


Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2026-02-24 @ 5:45 AM
Study NCT ID: NCT03740334
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-21
First Post: 2018-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module